FOXP1 and cancer: Deletion of the FOXP1-SHQ1 region is seen in a wide variety of cancers, ranging from 27% of primary breast cancer5 and stomach cancer6 to 70% or more in renal clear cell7 and head and neck8 cancers, often within larger deletions.